ICeram SA (France) Executives
| ALICR Stock | EUR 0.40 0.06 13.04% |
ICeram SA employs about 27 people. The company is managed by 3 executives with a total tenure of roughly 63 years, averaging almost 21.0 years of service per executive, having 9.0 employees per reported executive. Discussion of ICeram SA's management performance can provide insight into the enterprise performance.
| Eric Denes Insider Scientific Director |
| Andr Krisit Insider CEO Chairman |
ICeram |
ICeram SA Management Team Effectiveness
The company has return on total asset (ROA) of (0.0897) % which means that it has lost $0.0897 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3456) %, meaning that it generated substantial loss on money invested by shareholders. ICeram SA's management efficiency ratios could be used to measure how well ICeram SA manages its routine affairs as well as how well it operates its assets and liabilities.ICeram SA Workforce Comparison
ICeram SA is rated third in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 170. ICeram SA retains roughly 27.0 in number of employees claiming about 16% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.49) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.51) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.51. ICeram SA Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. ICeram SA Price Series Summation is a cross summation of ICeram SA price series and its benchmark/peer.
ICeram SA Notable Stakeholders
An ICeram SA stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ICeram SA often face trade-offs trying to please all of them. ICeram SA's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ICeram SA's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Eric Denes | Scientific Director | Profile | |
| Andr Krisit | CEO Chairman | Profile | |
| Sylvain Jung | Chief Director | Profile |
About ICeram SA Management Performance
The success or failure of an entity such as ICeram SA often depends on how effective the management is. ICeram SA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ICeram management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ICeram management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
I.CERAM SA designs, manufactures, and markets alumina bio-ceramic implants in France and internationally. The company was founded in 2005 and is based in Limoges, France. I CERAM operates under Medical Instruments Supplies classification in France and is traded on Paris Stock Exchange. It employs 44 people.
ICeram SA Workforce Analysis
Traditionally, organizations such as ICeram SA use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ICeram SA within its industry.ICeram SA Manpower Efficiency
Return on ICeram SA Manpower
| Revenue Per Employee | 79.6K | |
| Revenue Per Executive | 716.6K | |
| Net Loss Per Employee | 28.6K | |
| Net Loss Per Executive | 257.4K |
Additional Tools for ICeram Stock Analysis
When running ICeram SA's price analysis, check to measure ICeram SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICeram SA is operating at the current time. Most of ICeram SA's value examination focuses on studying past and present price action to predict the probability of ICeram SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICeram SA's price. Additionally, you may evaluate how the addition of ICeram SA to your portfolios can decrease your overall portfolio volatility.